Evidence map›Paper›PMID 38640238›Full record

ArticleScience advances2024

PTH treatment before cyclic joint loading improves cartilage health and attenuates load-induced osteoarthritis development in mice.

Adrien Y Antoinette, Sophia N Ziemian, Allison R Brown, Erin B Hudson, Carolyn Chlebek, Timothy M Wright, Steven R Goldring, Mary B Goldring, Miguel Otero, Marjolein C H van der Meulen

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Porous PLGA microspheres loaded with PTHJournal of orthopaedic translation · 2025
    Article
  6. [Pathology of Cartilage-to-Bone Crosstalk: A New Angle for Animal Experimental Studies on Osteoarthritis].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2025
    Review
  7. Article
  8. Review
  9. Bone-modifying drugs slow OA progression.Nature reviews. Rheumatology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Adrien Y AntoinetteCornell University, Ithaca, NY, USA.ORCID 0000-0001-8579-3377
Sophia N ZiemianCornell University, Ithaca, NY, USA.ORCID 0000-0003-0086-2156
Allison R BrownCornell University, Ithaca, NY, USA.ORCID 0009-0009-3303-4382
Erin B HudsonCornell University, Ithaca, NY, USA.
Carolyn ChlebekCornell University, Ithaca, NY, USA.ORCID 0000-0003-4782-3912
Timothy M WrightHospital for Special Surgery, New York, NY, USA.ORCID 0000-0001-7139-1908
Steven R GoldringHospital for Special Surgery, New York, NY, USA.
Mary B GoldringHospital for Special Surgery, New York, NY, USA.ORCID 0000-0001-5407-9293
Miguel OteroHospital for Special Surgery, New York, NY, USA.ORCID 0000-0002-4945-2994
Marjolein C H van der MeulenCornell University, Ithaca, NY, USA.ORCID 0000-0001-6637-9808
Cornell University · USHospital for Special Surgery · US

Funding

ORTHOPAEDIC RESEARCH TRAININGT32AR007281 · NIAMS · HOSPITAL FOR SPECIAL SURGERY · PI MAHER, SUZANNE A., VAN DER MEULEN, MARJOLEIN C · 1986 to 2018
$1.8M
NIAMS NIH HHS T32 AR007281
6 · The paper itself

Abstract

Osteoarthritis (OA) treatment is limited by the lack of effective nonsurgical interventions to slow disease progression. Here, we examined the contributions of the subchondral bone properties to OA development. We used parathyroid hormone (PTH) to modulate bone mass before OA initiation and alendronate (ALN) to inhibit bone remodeling during OA progression. We examined the spatiotemporal progression of joint damage by combining histopathological and transcriptomic analyses across joint tissues. The additive effect of PTH pretreatment before OA initiation and ALN treatment during OA progression most effectively attenuated load-induced OA pathology. Individually, PTH directly improved cartilage health and slowed the development of cartilage damage, whereas ALN primarily attenuated subchondral bone changes associated with OA progression. Joint damage reflected early transcriptomic changes. With both treatments, the structural changes were associated with early modulation of immunoregulation and immunoresponse pathways that may contribute to disease mechanisms. Overall, our results demonstrate the potential of subchondral bone-modifying therapies to slow the progression of OA.

Indexed as

Cartilage, ArticularOsteoarthritisParathyroid HormoneAlendronateAnimalsBone and BonesBone RemodelingMiceWeight-BearingAlendronateParathyroid Hormone

Identifiers

PMID38640238
PMCPMC11029811
OpenAlexW4394950988

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.